Platelet prothrombinase activity and intracellular calcium responses in patients with storage pool deficiency, glycoprotein IIb-IIIa deficiency, or impaired platelet coagulant activity - A comparison with Scott syndrome

Blood

Volumn 89, Issue 5, 1997, Pages 1599-1611

  Weiss, Harvey J ^a   Lages, Bruce ^b  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; BLOOD CLOTTING FACTOR 10A; FIBRINOGEN RECEPTOR;

ARTICLE; BLEEDING DISORDER; CALCIUM CELL LEVEL; ENZYME ACTIVATION; ENZYME ACTIVITY; GLANZMANN DISEASE; HUMAN; HUMAN CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 0031020349     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.5.1599     Document Type: Article

References (83)

1. Ware JA, Coller BS: Platelet morphology, biochemistry and function, in Beutler E, Lichtman MA, Coller BS, Kipps TJ (eds): Williams Hematology (ed 5). New York, NY, McGraw-Hill, 1995, p 1161
2. Weiss HJ: Flow-related platelet deposition on subendothelium. Thromb Haemost 74:117, 1995
3. Ruggeri ZM: New insights into the mechanisms of platelet adhesion and aggregation. Semin Hematol 31:229, 1994
4. Hawiger J: Adhesive interactions of blood cells and the vascular wall, in Colman RW, Hirsh J, Marder V, Salzman EW (eds): Hemostasis and Thrombosis: Basic Principles and Clinical Practice (ed 3). Philadelphia, PA, Lippincott, 1994, p 762
5. 3 integrins in hemostasis and vascular biology. Thromb Haemost 74:149, 1995
6. Shroit AJ, Zwaal RFA: Transbilayer movement of phospholipids in red cell and platelet membranes. Biochim Biophys Acta 1071:313, 1991
7. Mann KG, Krishnaswamy S, Lawson JH: Surface-dependent hemostasis. Semin Hematol 29:213, 1992
8. Zwaal RFA, Comfurius P, Bevers EM: Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis. Biochim Biophys Acta 1180:1, 1992
9. Walsh PN: Platelet-coagulant protein interactions, in Colman RW, Hirsh J, Marder VJ, Salzman EW (eds): Hemostasis and Thrombosis, Basic Principles and Clinical Practice (ed 3). Philadelphia, PA, Lippincott, p 629
10. Seigneuret M, Devaux PF: ATP-dependem asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: Relation to shape changes. Proc Natl Acad Sci USA 81:3751, 1984
11. Bevers EM, Rosing J, Zwaal RFA: Platelets and coagulation, in Maclntyre DE, Gordon JL (eds): Platelets in Biology and Pathology, vol III, New York, NY. Elsevier Science, 1987, p 127
12. Schick PK, Kuriea KB, Chacko GK: Location of phosphatidylethanolamine and phosphatidylserine in the human platelet plasma membrane. J Clin Invest 57:1221, 1976
13. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shatil SJ: Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: An isolated defect in platelet procoagulant activity. J Biol Chem 264:17049, 1989
14. Zwaal RFA, Revers EM, Comfurius P, Rosing J, Tilly RHJ, Verhallen PFJ: Loss of membrane phospholipid asymmetry during activation of blood platelets and sickled red cells: Mechanisms and physiological significance. Mol Cell Biochem 91:23, 1989
15. Sage SO, Sargeant P, Heemskerk JWM, Mahaut-Smith MP: Calcium influx mechanisms and signal organization in human platelets, in Authi KS, Watson SP, Kakkar VV (eds): Mechanisms of Platelet Activation and Control. New York, NY, Plenum, 1993, p 69
16. Rink TJ, Sage SO: Calcium signaling in human platelets. Annu Rev Physiol 52:431, 1990
17. Mann KG, Tracy PB, Kirshnaswamy S, Jenny RJ, Odegaard BH, Nesheim ME: Platelets and coagulation, in Verstrate M, Vermylen, Lijnen HR, Arnout J (eds): Thrombosis and Haemostasis. Leuven, Belgium, Leuven University, 1987, p 505
18. Bitbol M, Fellmann P, Zachowski A, Devaux PF: Phosphatidylserine exposed by platelet microvesiculation. Biochim Biophys Acta 904:268, 1987
19. Comfurius P, Senden JMG, Tilly RHJ, Schroit AJ, Bevers EM, Zwaal RFA: Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochim Biophys Acta 1026:153, 1990
20. Bevers EM, Comfurius P, van Rijn JLML, Hemker HC, Zwaal RFA: Generation of prothrombin converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 122:429, 1982
21. Williamson P, Bevers EM, Smeets EF, Comfurius P, Schlegel RA, Zwaal RFA: Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets. Biochemistry 34:10448, 1995
22. 2+ induces transbilayer redistribution of all major phospholipids in human erythrocytes. Biochemistry 31:6355, 1992
23. Comfurius P, Williamson P, Smeets EF, Schlegel RA, Bevers EM, Zwall RFA: Reconstitution of phospholipid scramblase activity from human blood platelets. Biochemistry 35:7631, 1996
24. 2+-dependent transbilayer movement of phospholipid. J Biol Chem 271:17205, 1996
25. Rosing J, Bevers EM, Comfurius P, Hemker HC, von Dieijen G, Weiss HJ, Zwaal RFA: Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder. Blood 65:1557, 1985
26. a binding sites on the platelets of a patient with a bleeding disorder. Blood 54:1015, 1979
27. Weiss HJ, Vicie WJ, Lages BA, Rogers J: Isolated deficiency of platelet procoagulant activity. Am J Med 67:206, 1979
28. Weiss HJ: Scott syndrome: A disorder of platelet coagulant activity (PCA). Semin Hematol 31:312, 1994
29. Toti F, Satta N, Fressinaud E, Meyer D, Freyssinet J-M: Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complication, is an inherited disorder. Blood 87:1409, 1996
30. Hardisty RM, Dormandy KM, Hutton RA: Thrombasthenia: Studies on three cases. Br J Haematol 10:371, 1964
31. Weiss HJ: Platelet aggregation, adhesion and ADP release in thrombopathia (platelet factor 3 deficiency)-A comparison with Glanzmann's thrombasthenia and von Willebrand's disease. Am J Med 43:570, 1967
32. Weiss HJ, Kochwa S: Studies of platelet function and proteins in three patients with Glanzmann's thrombasthenia. J Lab Clin Med 71:153, 1968
33. Caen JP, Castaldi PA, Leclerc JC: Congenital bleeding disorders with long bleeding time and normal platelet count. I. Glanzmann's thrombasthenia. Am J Med 41:4, 1966
34. Zucker MB, Pert JH, Hilgartner MW: Platelet function in a patient with thrombasthenia. Blood 28:524, 1966
35. Walsh PN: Platelet coagulant activities in thrombasthenia. Br J Haematol 23:533, 1972
36. Coller BS: Hereditary qualitative platelet disorders, in Beutler E, Lichtman MA, Coller BS, Kipps TJ (eds): Williams Hematology (ed 5). New York, NY, McGraw-Hill, 1995, p 1364
37. Moliterno DJ, Califf RM, Aguirre FV, Anderson K, Sigmon KN, Weisman HF, Topol EJ, for the EPIC Study Investigators: Activated clotting time is increased during coronary interventions with platelet glycoprotein IIb/IIIa integrin blockade: Results from the EPIC trial. Am J Cardiol 5:554, 1995
38. Bevers EM, Comfurius P, Nieuwenhuis HK, Levy-Toledano S, Enouf J, Belluci S, Caen JP, Zwaal RFA: Platelet prothrombin converting activity in hereditary disorders of platelet function. Br J Haematol 63:336, 1986
39. Weiss HJ, Turitto VT, Baumgartner HR: The role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium: Studies utilizing patients with quantitative and qualitative platelet defects. J Clin Invest 78:1072, 1986
40. Kirchhofer D, Tschopp TB, Steiner B, Baumgartner HR: Role of collagen-adherent platelets in mediating fibrin formation in flowing whole blood. Blood 86:3815, 1995
41. 2, platelet factor 4, and fibrinopeptide A in bleeding time blood of patients deficient in von Willebrand factor, platelet glycoproteins Ib, IIb-IIIa, and storage granules. Blood 82:481, 1993
42. Gemmell CH, Sefton MV, Yeo EL: Platelet derived microparticle formation involves glycoprotein IIb/IIIa. Inhibition by RGDS and Glanzmann's thrombasthenia defect. J Biol Chem 268:14586, 1993
43. Dachary-Prigent J, Freyssinet J-M, Pasquet J-M, Carron J-C, Nurden AT: Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: A flow cytometry study showing a role for free sulfhydryl groups. Blood 81:2554, 1993
44. Holmsen H, Weiss HJ: Further evidence for a deficient storage pool of adenine nucleotides in platelets from some patients with thrombocytopathia - "Storage pool disease." Blood 39:197, 1972
45. Weiss HJ, Witte LD, Kaplan KL, Lages BA, Chemoff A, Nossel HL, Goodman De WS, Baumgartner HR: Heterogeneity in storage pool deficiency: Studies on granule-bound substances in 18 patients including variants deficient in α-granules, platelet factor 4, β-thromboglobulin and platelet-derived growth factor. Blood 54:1296, 1979
46. Weiss HJ: Inherited abnormalities of platelet granules and signal transduction, in Colman RW, Hirsh J, Marder VJ, Salzman EW (eds): Hemostasis and Thrombosis: Basic Principles and Clinical Practice (ed 3). Philadelphia, PA, Lippincott, 1993, p 673
47. Monkovic DD, Tracy PB: Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin. J Biol Chem 265:17732, 1990
48. Weiss HJ, Pietu G, Meyer D, Rabinowitz R, Girma JP, Rogers J: Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma/platelet content of FVIII/vWf in classical (Type I) and three sub-types of variant (Type II) von Willebrand's disease. J Lab Clin Med 101:411, 1983
49. 2+, or K+. J Lab Clin Med 85:811, 1975
50. Wiedmer T, Esmon CT, Sims PJ: Complement proteins C5b-9 stimulate procoagulant activity through platelet prothrombinase. Blood 68:875, 1986
51. Lages B, Weiss HJ: Evidence for a role of glycoprotein IIb-IIIa, distinct from its ability to support aggregation, in platelet activation by ionophores in the presence of extracellular divalent cations. Blood 83:2549, 1994
52. Rink TJ, Pozzan T: Using quin2 in cell suspensions. Cell Calcium 6:133, 1985
53. Salvadori MG, Baron ML: Numerical methods in engineering. Englewood Cliffs, NJ, Prentice-Hall, 1964
54. Weiss HJ, Lages B, Vicic W, Tsung LY, White JG: Heterogeneous abnormalities of platelet dense granule ultrastructure in 20 patients with congenital storage pool deficiency. Br J Haematol 83:282, 1993
55. Lages BA, Holmsen H, Weiss HJ, Dangelmaier C: Thrombin and ionophore A23187-induced dense granule secretion in storage pool deficient platelets: Evidence for impaired nucleotide storage as the primary dense granule defect. Blood 61:154, 1983
56. Lages B, Shattil SJ, Bainton DF, Weiss HJ: Decreased content and surface expression of alpha-granule membrane protein GMP-140 in one of two types of platelet alpha-delta storage pool deficiency. J Clin Invest 87:919, 1991
57. Lages B, Sussman II, Levine SP, Coletti D, Weiss HJ: Platelet alpha granule deficiency associated with decreased P-selectin and selective impairment of thrombin-induced activation in a new patient with gray platelet syndrome (α-storage pool deficiency). J Lab Clin Med 129:364, 1997
58. Weiss HJ, Turitto VT, Baumgartner HR: Platelet adhesion and thrombus formation of subendothelium in platelets deficient in glycoprotein IIb-IIIa, Ib, and storage granules. Blood 67:322, 1986
59. Coller BS: A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet GPII/IIIa complex. J Clin Invest 76:101, 1985
60. Coller BS, Peerschke EI, Scudder LE, Sullivan CA: A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J Clin Invest 72:325, 1983
61. Chen F, Coller BS, Weiss HJ, Xu LZ, French DL: Glanzmann thrombasthenia due to a glycoprotein IIb missense mutation. Leu214 Pro. Thromb Haemost 73:1191, 1995 (abstr)
62. Ahmad SS, Rawala-Sheikh R, Ashby B, Walsh PN: Platelet receptor-mediated factor X activation by factor IXa: High-affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott syndrome. J Clin Invest 84:824, 1989
63. 2+ induced microvesiculation and deficient expression of procoagulant activity in erythrocytes from a , patient with a bleeding disorder: A study of the red blood cells of Scott syndrome. Blood 79:380, 1992
64. Kohima H, Newton-Nash D, Weiss HJ, Sims PJ, Zhao J, Wiedmer T: Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome. J Clin Invest 94:2237, 1994
65. a binding sites on their platelets. J Clin Invest 62:824, 1978
66. 66: Lages B, Dangelmaier CA, Holmsen H, Weiss HJ: Specific correction of impaired acid hydrolase secretion in storage pool deficient platelets by adenosine diphosphate. J Clin Invest 81:1865, 1988
67. 3+-induced loss of phospholipid asymmetry in the human erythrocyte. A study in Scott syndrome, a disorder of calcium-induced phospholipid scrambling. Blood 86:1983, 1995
68. Srivastava PC, Powling MJ, Nokes TJC, Patrick AD, Dawes J, Hardisty RM: Grey platelet syndrome: Studies on platelet alpha-granules, lysosomes and defective response to thrombin. Br J Haematol 65:441, 1987
69. Tracy PB, Giles AR, Mann KG: Factor V (Quebec): A bleeding diathesis associated with a qualitative platelet factor V deficiency. J Clin Invest 74:1221, 1984
70. Hayward CPM, Rivard GE, Kane WH, Drouin J, Zheng S, Moore JC, Kelton JG: An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defect. Blood 87:4967, 1996
71. Hayward CPM, Furmaniak-Kazmierczak E, Cieutat A-M, Moore JC, Bainton DF, Nesheim ME, Kelton JG, Cote G: Factor V is complexed with multimerin in resting platelet lysates and colocalizes with multimerin in platelet α-granules. J Biol Chem 270:19217, 1995
72. Janeway CM, Rivard GE, Tracy PB, Mann KG: Factor V Quebec revisited. Blood 87:3571, 1996
73. Reverter JC, Kessels H, Beguin S, Kumar R, Hemker HC, Coller BS: Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. J Clin Invest 98:863, 1996
74. 2+ store. Biochem J 265:675, 1990
75. 2+ on the surface of platelets. J Clin Invest 73:626, 1984
76. 2+ transport across the platelet plasma membrane. A role for membrane glycoproteins IIB and IIIA. J Biol Chem 260:2231, 1985
77. Rybak MEM, Renzulli LA: Effect of calcium channel blockers on platelet GPIIb-IIIa as a calcium channel in liposomes: Comparison with effects on the intact platelet. Thromb Haemost 67:131, 1992
78. Yamaguchi A, Tanour K, Yamazaki H: Secondary signals mediated by GPIIb/IIIa in thrombin-activated platelets. Biochim Biophys Acta 1054:8, 1990
79. 2+ or cyclic AMP. Biochem J 270:149, 1990
80. 2+ influx into stimulated platelets. Blood 66:731, 1985
81. Sinigaglia F, Bisio A, Torti M, Balduini CL, Bertolino G, Balduini C: Effect of GPIIb/IIIa complex ligands on calcium ion movement and cytoskeleton organization in activated platelets. Biochem Biophys Res Commun 154:258, 1988
82. Cadroy Y, Hanson SR, Andrew BK, Marzec UM, Evatt BL, Kunicki TJ, Montgomery RR, Harker LA: Relative antithrombotic effects of monoclonal antibodies targeting different platelet glycoprotein-adhesive molecule interactions in nonhuman primates. Blood 83:3218, 1994
83. Coller BS, Anderson K, Weisman HF: New antiplatelet agents: Platelet GPIIb/IIIa antagonists. Thromb Haemost 74:302, 1995